Compound ID | 559
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive |
| Details of activity: | Demonstrated similar activity against S. pneumoniae, S. pyogenes, E. coli, E. aerogenes and K ooxytoca than ofloxacin, tosufloxacin and sparfloxacin. |
| Description: | Maejima T, Senda H, Iwatani W, et al. Potent antibacterial activity of S-32730, a new fluoroquinolone,, against Gram-positive bacteria including quinolone-resistant MRSA. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 146 |
| Institute where first reported: | Kaken Pharmaceutical Co., Japan |
| Year first mentioned: | 1995 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: | https://link.springer.com/article/10.2165/00003495-199958002-00001 |